A detailed history of D. E. Shaw & Co., Inc. transactions in Danaher Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 23,100 shares of DHR stock, worth $5.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
23,100
Holding current value
$5.33 Million
% of portfolio
0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$239.25 - $280.76 $585,684 - $687,300
2,448 Added 90.67%
5,148 $1.43 Million
Q2 2024

Aug 14, 2024

SELL
$235.51 - $267.98 $706,294 - $803,672
-2,999 Reduced 52.62%
2,700 $674,000
Q1 2024

May 15, 2024

SELL
$224.58 - $256.19 $4.33 Million - $4.93 Million
-19,263 Reduced 77.17%
5,699 $1.42 Million
Q4 2023

Feb 14, 2024

SELL
$185.1 - $233.13 $29 Million - $36.6 Million
-156,891 Reduced 86.27%
24,962 $5.77 Million
Q3 2023

Nov 14, 2023

SELL
$233.08 - $265.59 $165 Million - $188 Million
-709,721 Reduced 79.6%
181,853 $45.1 Million
Q2 2023

Aug 14, 2023

BUY
$224.99 - $256.14 $70.6 Million - $80.4 Million
313,798 Added 54.31%
891,574 $214 Million
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $52 Million - $60 Million
216,776 Added 60.05%
577,776 $146 Million
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $48 Million - $56.1 Million
198,899 Added 122.7%
361,000 $95.8 Million
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $17.1 Million - $104 Million
-69,089 Reduced 29.88%
162,101 $41.9 Million
Q2 2022

Aug 15, 2022

BUY
$237.11 - $299.66 $34.9 Million - $44.1 Million
147,101 Added 174.93%
231,190 $58.6 Million
Q1 2022

May 16, 2022

BUY
$257.27 - $315.76 $4.4 Million - $5.4 Million
17,112 Added 25.55%
84,089 $24.7 Million
Q4 2021

Feb 14, 2022

SELL
$292.08 - $329.01 $38.5 Million - $43.4 Million
-131,880 Reduced 66.32%
66,977 $22 Million
Q3 2021

Nov 15, 2021

BUY
$272.21 - $332.43 $47.3 Million - $57.8 Million
173,723 Added 691.19%
198,857 $60.5 Million
Q2 2021

Aug 16, 2021

SELL
$225.08 - $271.69 $22.9 Million - $27.7 Million
-101,863 Reduced 80.21%
25,134 $6.75 Million
Q1 2021

May 17, 2021

SELL
$212.38 - $245.9 $3.05 Million - $3.53 Million
-14,373 Reduced 10.17%
126,997 $28.6 Million
Q4 2020

Feb 16, 2021

BUY
$212.5 - $245.46 $18.4 Million - $21.2 Million
86,392 Added 157.14%
141,370 $31.4 Million
Q3 2020

Nov 16, 2020

BUY
$177.16 - $215.33 $880,308 - $1.07 Million
4,969 Added 9.94%
54,978 $11.8 Million
Q2 2020

Aug 14, 2020

SELL
$128.7 - $176.83 $29.4 Million - $40.5 Million
-228,804 Reduced 82.06%
50,009 $8.84 Million
Q1 2020

May 15, 2020

BUY
$121.39 - $169.05 $23.2 Million - $32.4 Million
191,520 Added 219.4%
278,813 $38.6 Million
Q4 2019

Feb 14, 2020

SELL
$133.47 - $153.48 $26.4 Million - $30.4 Million
-197,883 Reduced 69.39%
87,293 $13.4 Million
Q3 2019

Nov 14, 2019

BUY
$135.4 - $146.47 $2.71 Million - $2.93 Million
19,996 Added 7.54%
285,176 $41.2 Million
Q2 2019

Aug 14, 2019

BUY
$124.88 - $143.73 $28.3 Million - $32.5 Million
226,305 Added 582.14%
265,180 $37.9 Million
Q1 2019

May 15, 2019

SELL
$97.62 - $132.29 $37 Million - $50.2 Million
-379,156 Reduced 90.7%
38,875 $5.13 Million
Q4 2018

Feb 14, 2019

SELL
$94.85 - $109.54 $170 Million - $197 Million
-1,795,870 Reduced 81.12%
418,031 $43.1 Million
Q3 2018

Nov 14, 2018

BUY
$98.13 - $108.9 $9.81 Million - $10.9 Million
99,925 Added 4.73%
2,213,901 $241 Million
Q2 2018

Aug 14, 2018

BUY
$96.1 - $103.24 $82.8 Million - $89 Million
861,651 Added 68.8%
2,113,976 $209 Million
Q1 2018

May 15, 2018

SELL
$92.16 - $103.8 $39 Million - $43.9 Million
-422,742 Reduced 25.24%
1,252,325 $123 Million
Q4 2017

Feb 14, 2018

BUY
$85.26 - $94.62 $7.41 Million - $8.22 Million
86,926 Added 5.47%
1,675,067 $155 Million
Q3 2017

Nov 14, 2017

BUY
$79.29 - $88.45 $126 Million - $140 Million
1,588,141
1,588,141 $136 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.